Conference Description

March 31, 2007
Medical Forum at the Sheraton Birmingham
950 22nd Street North
Birmingham, AL 35203
(205) 324-5000

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 8.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. discuss how given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statistically significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
2. more fully understand the major contributors to premature and excess cardiovascular disease in diabetes and the role of the curently available antihyperglycemic agents, specifically the thiazolidinediones, in its prevention
3. decide when, how, and which insulin to start when managing patients with Type 2 Diabetes, and better understand available options for treating post-prandial hyperglycemia, as well as the role incretin hormones play in the management of diabetes
4. appreciate recent advances in our understanding of the neurobiology of sleep-wake regulation, and understand behavioral and pharmacological approaches to insomnia including their application in the clinical setting
5. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life
6. recognize common skin problems like Acne and Rosacea and, after understanding their pathogenesis, offer effective, state of the art treatment options
7. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predominant irritable bowel syndrome and chronic constipation
8. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical interventions for BPH
9. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, nontraditional, and alternative medical interventions for addressing menopausal symptoms

Agenda:

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:00		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD
9:00-9:50		Preventing Premature & Excess Cardiovascular Disease in Type 2 Diabetes Fernando Ovalle, MD
9:50-10:10		Break
10:10-11:00		The Role of Insulin and Incretins in the Current Management of Type 2 Diabetes: An Interactive Case Presentation & Discussion Fernando Ovalle, MD
11:00-11:50		Science of Sleep: Implications for Insomnia Phyllis C. Zee, MD
11:50-12:40		Restless Legs, Restless Nights Phyllis C. Zee, MD
12:40-1:30		Lunch
1:30-2:20		Acne and Rosacea Update Julie Harper, MD
2:20-3:10		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Brooks D. Cash, MD
3:10-3:30		Break
3:30-4:20		Effective Managment of BPH by the Primary Care Clinician Louis Kuritzky, MD
4:20-5:10		Hormone Replacement Therapy: Balancing Risks and Benefits Louis Kuritzky, MD
5:10-5:20		Conference Wrap Up and Post-Assessment Gregg Sherman, MD

Faculty:
Brooks D. Cash, MD, FACP, FACG, CDR, MC, USN
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine, USUHS
National Naval Medical Center
Bethesda, MD

Julie Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama – Birmingham
Birmingham, AL

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health
at the University of Miami School of Medicine
Miami, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainseville, FL

Fernando Ovalle, MD
Associate Professor of Medicine
University of Alabama at Birmingham
Birmingham, AL

Phyllis C. Zee, MD, PhD
Professor of Neurology and Neurobiology & Physiology
Northwestern University
Chicago, Il

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 8.0 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 7.5 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 9 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, Novo nordisk, sanofi-aventis, Takeda, Wyeth.